A major shift inside federal healthcare policy could reshape how AI is used in medicine, and most of the broader tech market still has not caught on.
The change centers on ACCESS, a new Medicare payment model from the Centers for Medicare & Medicaid Services that rewards outcomes instead of simply reimbursing providers for time spent or a list of required activities. That distinction matters. In healthcare, even the most promising technology struggles to scale unless the payment system supports it. ACCESS appears to create a path for AI-powered care tools to move from pilot programs into real operating models.
Pair Team is one of 150 participants selected for the program, which was announced on April 30, 2026 and is scheduled to go live on July 5, 2026. The model, formally known as Advancing Chronic Care with Effective, Scalable Solutions, is a 10-year initiative focused on patients living with chronic conditions such as diabetes, hypertension, chronic kidney disease, obesity, depression, and anxiety.
That may sound like a niche policy update, but the implications are far broader. Traditional Medicare has generally paid clinicians for visits, check-ins, and specific documented services. It has not been built to reimburse an AI system that follows up with patients between appointments, helps manage referrals, checks medication adherence, or keeps people engaged in their care on a daily basis. ACCESS changes the economics by putting more emphasis on whether a patient actually improves.
For companies that have spent years building AI-assisted care infrastructure, this is the kind of regulatory shift that can unlock an entirely new growth curve.
Pair Team has positioned itself around a part of healthcare that many startups have historically overlooked: high-need patients dealing with both chronic illness and social instability. The company focuses on people whose health outcomes are often shaped not just by medical treatment, but also by housing insecurity, food access, transportation barriers, and behavioral health needs. That broader care model now looks well aligned with a payment system that rewards results instead of fragmented service volume.
What makes Pair Team especially notable in this moment is its use of AI as part of front-line patient engagement. The company deployed a voice AI agent called Flora as its primary patient-facing interface, using it for intake, check-ins, referral coordination, and ongoing communication. In practical terms, that means Pair Team is not talking about AI as a future capability. It is already using it to extend care capacity between clinical encounters, exactly the kind of function that older reimbursement systems have struggled to support.
There is some evidence behind the broader model. A study referenced in the reporting and peer-reviewed by the Journal of General Internal Medicine evaluated Pair Team’s community-integrated care approach for Medicaid patients facing homelessness, serious mental illness, and chronic disease. The findings pointed to strong patient engagement and reductions in avoidable emergency department and inpatient utilization.
That does not mean the opportunity comes without risk.
Any expansion of AI in healthcare raises serious questions about privacy, oversight, and data governance. These systems may handle highly sensitive information involving physical health, mental health, housing instability, and other deeply personal circumstances. Scaling that kind of infrastructure through federal programs will inevitably invite scrutiny over how patient data is stored, protected, and used. The report also noted concerns tied to prior data exposure issues within federal systems.
There is also the question of whether the business math works. A 2023 Congressional Budget Office analysis found that the CMS Innovation Center increased federal spending by $5.4 billion during its first decade instead of generating projected savings. That history does not predetermine the outcome for ACCESS, but it does highlight how difficult healthcare payment reform can be, even when the underlying policy goals are widely supported.
Still, ACCESS stands out because it aligns three forces that do not often move together: public reimbursement, measurable outcomes, and AI-driven care delivery. If the model succeeds, it could help validate a new generation of healthcare companies built not around one-off apps or isolated software products, but around AI-supported operating systems for chronic care.
That would be a meaningful shift for both healthcare and tech. For years, startups have pitched AI tools that promise to reduce administrative burden, improve patient engagement, and lower costs. Many of those claims have been difficult to monetize inside a reimbursement system designed for older care structures. ACCESS could change that by making continuous, technology-enabled care financially viable for organizations that can deliver results.
In that sense, Pair Team may be less of an outlier than an early indicator of where the market is heading. The biggest AI healthcare winners may not be the loudest consumer brands or the flashiest demo-driven startups. They may be the companies that quietly built for regulated environments, vulnerable populations, and outcome-based payment long before the rest of tech noticed.
For Silicon Valley, this may be one of the most important AI stories unfolding right now. It is just happening through Medicare policy instead of a product keynote.
